glp 1 zepbound tirzepatide Decoding GLP-1 Weight Loss Medications FDA approval for Zepbound (tirzepatide)
Description
Diabetes 60 , 12701276 (2011)
The medication also slows gastric emptying, which prolongs the feeling of fullness after meals and reduces postprandial glucose excursions
While this supports weight loss, it can take a little time for your body to adjust
These effects are typically mild to moderate and decrease over time
Understanding proper tirzepatide storage is essential for both medication efficacy and injection comfort
Dr Sundar is wonderful and so thorough
